These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histopathology of cryptococcosis and other fungal infections in patients with acquired immunodeficiency syndrome. Shibuya K, Coulson WF, Wollman JS, Wakayama M, Ando T, Oharaseki T, Takahashi K, Naoe S. Int J Infect Dis; 2001; 5(2):78-85. PubMed ID: 11468102 [Abstract] [Full Text] [Related]
4. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. Aberg JA, Price RW, Heeren DM, Bredt B. J Infect Dis; 2002 Apr 15; 185(8):1179-82. PubMed ID: 11930330 [Abstract] [Full Text] [Related]
5. Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis. Ramdial PK, Sing Y, Subrayan S, Calonje E. Am J Dermatopathol; 2010 Dec 15; 32(8):780-6. PubMed ID: 20802305 [Abstract] [Full Text] [Related]
12. [Mycotic infection in immunosuppressed patients. An anatomopathologic study]. Brocheriou C, Badillet G, Gluckman E, Kuffer R, de Roquancourt A, Verola O, D'Agay MF, Lesourd A. Ann Pathol; 1990 Jul 15; 10(2):99-108. PubMed ID: 2189427 [Abstract] [Full Text] [Related]
16. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F, de Andrade HF, Fernandes ER, Tuon FF, Brasil RA, Pagliari C, Duarte MI. Br J Dermatol; 2008 Sep 15; 159(4):839-46. PubMed ID: 18644020 [Abstract] [Full Text] [Related]